Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-30 @ 3:25 AM
Study NCT ID:
NCT07476261
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-17
First Post:
2026-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Incidence of Ssi After c.s
Sponsor:
Assiut University
Organization:
Study Overview
Official Title:
Incidence of Surgical Site Infection After Cesarean Section and Compliance With Surgical Site Infection Prevention Stratigies .
Status:
NOT_YET_RECRUITING
Status Verified Date:
2026-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.
Detailed Description:
Cesarean Section is one of the most commonly performed obstetric surgical procedures worldwide. Despite its importance in reducing maternal and fetal complications, it is associated with several postoperative complications, the most important of which is Surgical Site Infection. Surgical site infection after cesarean section can lead to increased maternal morbidity, prolonged hospital stay, and higher healthcare costs. Therefore, evaluating the incidence of surgical site infection and assessing adherence to preventive measures are essential for improving the quality of obstetric care. This study aims to determine the incidence of surgical site infection after cesarean section and to assess compliance with infection prevention strategies.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: